The application and functional mechanism of Chinese herbal medicines in the treatment of chronic hepatitis B

被引：0
作者：
Zhang, Jiao [1 ]
Ma, Junrui [2 ]
Dai, Hongyang [1 ]
Zhang, Hushan [1 ]
机构：
[1] Zhaotong Hlth Vocat Coll, Zhaotong 657000, Yunnan, Peoples R China
[2] Yunnan Univ Tradit Chinese Med, Sch Nursing, Kunming 650022, Yunnan, Peoples R China
来源：
FUTURE VIROLOGY | 2024年 / 19卷 / 8-9期
关键词：
active compounds; chronic hepatitis B (CHB); Hepatitis B virus (HBV); mechanism; traditional Chinese medicine (TCM); LIVER FIBROSIS; VIRUS; PROLIFERATION; INJECTION; APOPTOSIS; ENTRY;
D O I：
10.1080/17460794.2024.2388479
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Hepatitis B, caused by the hepatitis B Virus (HBV), is an inflammatory liver disease that poses a significant threat to public health. HBV, a hepatotropic DNA virus, can cause chronic and acute Hepatitis B and persistent infection may cause serious complications like cirrhosis, liver cancer, and liver failure. Though nucleos(t)ide analogues (NAs) is the first-line drug for chronic hepatitis B (CHB), they still have several drawbacks such as drug resistance, and low-level viremia. Recent studies suggest that traditional Chinese medicine (TCM) and its active ingredients can inhibit HBV activity and replication, indicating their potentials for CHB treatment. This article focuses on the anti HBV activity and mechanism of TCM, aiming to help develop new anti-HBV drugs and improve the cure rate of CHB.
引用
收藏
页码：325 / 338
页数：14
相关论文
共 85 条
  • [11] Cheng D Y, 2023, Zhonghua Gan Zang Bing Za Zhi, V31, P608, DOI 10.3760/cma.j.cn501113-20230217-00065
  • [12] Fuzheng Huayu inhibits carbon tetrachloride-induced liver fibrosis in mice through activating hepatic NK cells
    Cheng, Qi
    Li, Ning
    Chen, Mingquan
    Zheng, Jianming
    Qian, Zhiping
    Wang, Xinyu
    Huang, Chong
    Li, Qian
    Lin, Qingxia
    Shi, Guangfeng
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2013, 145 (01) : 175 - 181
  • [13] Comparison on different traditional Chinese medicine therapies for chronic hepatitis B liver fibrosis
    Dai, Yun-kai
    Fan, Hai-na
    Hu, Yong-hong
    Zhao, Zhi-min
    Liu, Chenghai
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [14] Beneficial Effects of Traditional Chinese Medicine Fuzheng Huayu on the Occurrence of Hepatocellular Carcinoma in Patients with Compensated Chronic Hepatitis B Cirrhosis Receiving Entecavir: A Multicenter Retrospective Cohort Study
    Fan, Haina
    Lei, Shujuan
    Zhao, Zhimin
    Huang, Yan
    Wang, Hui
    Liu, Xudong
    Li, Xiaodong
    Xu, Min
    Zhang, Wei
    Sun, Kewei
    Xing, Huichun
    Mei, Yang
    Huang, Jiaquan
    Zhu, Chuanwu
    Zhang, Kejun
    Zong, Yali
    Shen, Xizhong
    Xie, Qing
    Liu, Chenghai
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2024, 12 (05) : 505 - 515
  • [15] Pharmacological action of Hedysarum polysaccharides: a review
    Gao, Xiang
    Ren, Chunzhen
    Li, Linyu
    Zhao, Huilin
    Liu, Kai
    Zhuang, Mengjie
    Lv, Xinfang
    Zhi, Xiaodong
    Jiang, Hugang
    Chen, Qilin
    Zhao, Xinke
    Li, Yingdong
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [16] Inhibition of hepatitis B virus via selective apoptosis modulation by Chinese patent medicine Liuweiwuling Tablet
    Ge, Fei-Lin
    Yang, Yan
    Si, Lan-Lan
    Li, Yuan-Hua
    Cao, Meng-Zhen
    Wang, Jun
    Bai, Zhao-Fang
    Ren, Zhi-Gang
    Xiao, Xiao-He
    Liu, Yan
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (13) : 1911 - 1925
  • [17] Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppressed HBV Replication in Mouse Model
    Ge, Fei-lin
    Si, Lan-lan
    Yang, Yan
    Li, Yuan-hua
    Lv, Zhong-lin
    Liu, Wen-hui
    Liao, Hao
    Wang, Jun
    Zou, Jun
    Li, Le
    Li, Hui
    Zhang, Zi-lin
    Wang, Jia-bo
    Lu, Xue-chun
    Xu, Dong-ping
    Bai, Zhao-fang
    Liu, Yan
    Xiao, Xiao-he
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [18] The role of Traditional Chinese medicine in anti-HBV: background, progress, and challenges
    Ge, Feilin
    Yang, Yan
    Bai, Zhaofang
    Si, Lanlan
    Wang, Xuemei
    Yu, Jia
    Xiao, Xiaohe
    Liu, Yan
    Ren, Zhigang
    [J]. CHINESE MEDICINE, 2023, 18 (01)
  • [19] Anti-hepatitis B virus effects of the traditional Chinese herb Arteinisia capillaris and its active enynes
    Geng, Chang-An
    Yang, Tong-Hua
    Huang, Xiao-Yan
    Yang, Jing
    Ma, Yun-Bao
    Li, Tian-Ze
    Zhang, Xue-Mei
    Chen, Ji-Jun
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2018, 224 : 283 - 289
  • [20] Three new anti-HBV active constituents from the traditional Chinese herb of Yin-Chen (Artemisia scoparia)
    Geng, Chang-An
    Huang, Xiao-Yan
    Chen, Xing-Long
    Ma, Yun-Bao
    Rong, Guang-Qing
    Zhao, Yong
    Zhang, Xue-Mei
    Chen, Ji-Jun
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2015, 176 : 109 - 117
123456789